Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi, Paolo Macor, Federica Banterla, Elena Bresin, Claudio Tripodo, Serena Bettoni, Roberta Donadelli, Elisabetta Valoti, Francesco Tedesco, Alessandro Amore, Rosanna Coppo, Piero Ruggenenti, Eliana Gotti, Giuseppe Remuzzi

Blood (2014) 124 (11): 1715–1726.

https://doi.org/10.1182/blood-2014-02-558296

Published: 2014

Includes: Supplemental data

Journal Articles

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Manfred Rieger, Pier Mannuccio Mannucci, Johanna A. Kremer Hovinga, Andrea Herzog, Gabi Gerstenbauer, Christian Konetschny, Klaus Zimmermann, Inge Scharrer, Flora Peyvandi, Miriam Galbusera, Giuseppe Remuzzi, Martina Böhm, Barbara Plaimauer, Bernhard Lämmle, Friedrich Scheiflinger

Blood (2005) 106 (4): 1262–1267.

https://doi.org/10.1182/blood-2004-11-4490

Published: 2005

Journal Articles

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report

Miriam Galbusera, Elena Bresin, Marina Noris, Sara Gastoldi, Daniela Belotti, Cristina Capoferri, Erica Daina, Paolo Perseghin, Friedrich Scheiflinger, Fadi Fakhouri, Jean-Pierre Grünfeld, Enrico Pogliani, Giuseppe Remuzzi

Blood (2005) 106 (3): 925–928.

https://doi.org/10.1182/blood-2004-12-4885

Published: 2005

Journal Articles

Regulation of High Shear Rate Induced von Willebrand Factor Mediated Platelet Thrombi by ADAMTS-13 .

Roberta Donadelli, PhD, Jennifer N. Orje, PhD, Miriam Galbusera, MD, Giuseppe Remuzzi, MD, Zaverio M. Ruggeri

Blood (2004) 104 (11): 516.

https://doi.org/10.1182/blood.V104.11.516.516

Published: 2004

Journal Articles

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

Roberta Donadelli, Biol.Sci.D, Federica Banterla, Biol.Sci.D, Cristina Capoferri, Biol.Sci.D, Miriam Galbusera, Biol.Sci.D, Zaverio M. Ruggeri, M.D., Sara Bucchioni, Biol.Sci.D, Marina Noris, Chem Pharm D, Giuseppe Remuzzi, M.D.

Blood (2004) 104 (11): 513.

https://doi.org/10.1182/blood.V104.11.513.513

Published: 2004

Journal Articles

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Giuseppe Remuzzi, Miriam Galbusera, Marina Noris, Maria Teresa Canciani, Erica Daina, Elena Bresin, Silvia Contaretti, Jessica Caprioli, Sara Gamba, Piero Ruggenenti, Norberto Perico, Pier Mannuccio Mannucci

Blood (2002) 100 (3): 778–785.

https://doi.org/10.1182/blood-2001-12-0166

Published: 2002

Journal Articles

Verotoxin-1–induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress

Marina Morigi, Miriam Galbusera, Elena Binda, Barbara Imberti, Sara Gastoldi, Andrea Remuzzi, Carla Zoja, Giuseppe Remuzzi

Blood (2001) 98 (6): 1828–1835.

https://doi.org/10.1182/blood.V98.6.1828

Published: 2001

Journal Articles

Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families

Miriam Galbusera, Marina Noris, Chiara Rossi, Silvia Orisio, Jessica Caprioli, Zaverio M. Ruggeri, Barbara Amadei, Piero Ruggenenti, Beatrice Vasile, Giorgio Casari, Giuseppe Remuzzi

Blood (1999) 94 (2): 610–620.

https://doi.org/10.1182/blood.V94.2.610

Published: 1999

Journal Articles

Fluid Shear Stress Modulates von Willebrand Factor Release From Human Vascular Endothelium

Miriam Galbusera, Carla Zoja, Roberta Donadelli, Simona Paris, Marina Morigi, Ariela Benigni, Marina Figliuzzi, Giuseppe Remuzzi, Andrea Remuzzi

Blood (1997) 90 (4): 1558–1564.

https://doi.org/10.1182/blood.V90.4.1558

Published: 1997

NARROW

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report

Regulation of High Shear Rate Induced von Willebrand Factor Mediated Platelet Thrombi by ADAMTS-13 .

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Verotoxin-1–induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress

Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families

Fluid Shear Stress Modulates von Willebrand Factor Release From Human Vascular Endothelium

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only